vs

Side-by-side financial comparison of LAMAR ADVERTISING CO (LAMR) and Sotera Health Co (SHC). Click either name above to swap in a different company.

LAMAR ADVERTISING CO is the larger business by last-quarter revenue ($528.0M vs $303.4M, roughly 1.7× Sotera Health Co). LAMAR ADVERTISING CO runs the higher net margin — 19.3% vs 11.5%, a 7.8% gap on every dollar of revenue. On growth, Sotera Health Co posted the faster year-over-year revenue change (4.6% vs 4.5%). LAMAR ADVERTISING CO produced more free cash flow last quarter ($152.3M vs $52.4M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs -3.4%).

Lamar Advertising Company is an advertising company which operates billboards, logo signs, and transit displays in the United States and Canada. The company was founded in 1902 by Charles W. Lamar and J.M. Coe, and is headquartered in Baton Rouge, Louisiana. The company has over 200 locations in the United States and Canada. They have reportedly more than 363,000 displays across the USA. Lamar Advertising Company became a real estate investment trust in 2014.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

LAMR vs SHC — Head-to-Head

Bigger by revenue
LAMR
LAMR
1.7× larger
LAMR
$528.0M
$303.4M
SHC
Growing faster (revenue YoY)
SHC
SHC
+0.1% gap
SHC
4.6%
4.5%
LAMR
Higher net margin
LAMR
LAMR
7.8% more per $
LAMR
19.3%
11.5%
SHC
More free cash flow
LAMR
LAMR
$99.9M more FCF
LAMR
$152.3M
$52.4M
SHC
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
-3.4%
LAMR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LAMR
LAMR
SHC
SHC
Revenue
$528.0M
$303.4M
Net Profit
$101.8M
$34.8M
Gross Margin
54.7%
Operating Margin
27.7%
23.2%
Net Margin
19.3%
11.5%
Revenue YoY
4.5%
4.6%
Net Profit YoY
-26.9%
182.8%
EPS (diluted)
$1.00
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LAMR
LAMR
SHC
SHC
Q1 26
$528.0M
Q4 25
$595.9M
$303.4M
Q3 25
$585.5M
$311.3M
Q2 25
$579.3M
$294.3M
Q1 25
$505.4M
$254.5M
Q4 24
$579.6M
$290.2M
Q3 24
$564.1M
$285.5M
Q2 24
$565.3M
$276.6M
Net Profit
LAMR
LAMR
SHC
SHC
Q1 26
$101.8M
Q4 25
$152.3M
$34.8M
Q3 25
$141.8M
$48.4M
Q2 25
$154.4M
$8.0M
Q1 25
$138.8M
$-13.3M
Q4 24
$-1.2M
$12.3M
Q3 24
$147.5M
$17.0M
Q2 24
$137.4M
$8.8M
Gross Margin
LAMR
LAMR
SHC
SHC
Q1 26
Q4 25
67.7%
54.7%
Q3 25
67.9%
57.0%
Q2 25
67.8%
56.6%
Q1 25
64.4%
53.2%
Q4 24
67.8%
56.6%
Q3 24
67.6%
55.4%
Q2 24
67.6%
55.2%
Operating Margin
LAMR
LAMR
SHC
SHC
Q1 26
27.7%
Q4 25
32.9%
23.2%
Q3 25
32.3%
23.4%
Q2 25
34.1%
6.4%
Q1 25
37.8%
-5.8%
Q4 24
6.3%
30.0%
Q3 24
33.1%
28.2%
Q2 24
32.6%
27.8%
Net Margin
LAMR
LAMR
SHC
SHC
Q1 26
19.3%
Q4 25
25.6%
11.5%
Q3 25
24.2%
15.5%
Q2 25
26.6%
2.7%
Q1 25
27.5%
-5.2%
Q4 24
-0.2%
4.2%
Q3 24
26.1%
6.0%
Q2 24
24.3%
3.2%
EPS (diluted)
LAMR
LAMR
SHC
SHC
Q1 26
$1.00
Q4 25
$1.50
$0.12
Q3 25
$1.40
$0.17
Q2 25
$1.52
$0.03
Q1 25
$1.35
$-0.05
Q4 24
$-0.02
$0.05
Q3 24
$1.44
$0.06
Q2 24
$1.34
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LAMR
LAMR
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$39.3M
$344.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$981.7M
$606.0M
Total Assets
$6.9B
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LAMR
LAMR
SHC
SHC
Q1 26
$39.3M
Q4 25
$64.8M
$344.6M
Q3 25
$22.0M
$299.2M
Q2 25
$55.7M
$332.4M
Q1 25
$36.1M
$304.4M
Q4 24
$49.5M
$277.2M
Q3 24
$29.5M
$306.7M
Q2 24
$77.9M
$246.1M
Total Debt
LAMR
LAMR
SHC
SHC
Q1 26
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Stockholders' Equity
LAMR
LAMR
SHC
SHC
Q1 26
$981.7M
Q4 25
$1.0B
$606.0M
Q3 25
$1.0B
$550.5M
Q2 25
$906.9M
$511.3M
Q1 25
$1.0B
$414.1M
Q4 24
$1.0B
$404.9M
Q3 24
$1.2B
$470.2M
Q2 24
$1.2B
$422.8M
Total Assets
LAMR
LAMR
SHC
SHC
Q1 26
$6.9B
Q4 25
$6.9B
$3.3B
Q3 25
$6.8B
$3.2B
Q2 25
$6.7B
$3.2B
Q1 25
$6.5B
$3.1B
Q4 24
$6.6B
$3.1B
Q3 24
$6.5B
$3.1B
Q2 24
$6.6B
$3.1B
Debt / Equity
LAMR
LAMR
SHC
SHC
Q1 26
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LAMR
LAMR
SHC
SHC
Operating Cash FlowLast quarter
$103.1M
Free Cash FlowOCF − Capex
$152.3M
$52.4M
FCF MarginFCF / Revenue
28.9%
17.3%
Capex IntensityCapex / Revenue
6.3%
16.7%
Cash ConversionOCF / Net Profit
2.96×
TTM Free Cash FlowTrailing 4 quarters
$737.7M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LAMR
LAMR
SHC
SHC
Q1 26
Q4 25
$271.2M
$103.1M
Q3 25
$235.7M
$71.2M
Q2 25
$229.5M
$57.4M
Q1 25
$127.7M
$55.5M
Q4 24
$279.3M
$55.7M
Q3 24
$227.4M
$97.5M
Q2 24
$256.3M
$61.3M
Free Cash Flow
LAMR
LAMR
SHC
SHC
Q1 26
$152.3M
Q4 25
$208.3M
$52.4M
Q3 25
$185.8M
$35.0M
Q2 25
$191.3M
$26.2M
Q1 25
$97.9M
$35.6M
Q4 24
$236.3M
$-10.2M
Q3 24
$197.3M
$61.1M
Q2 24
$233.7M
$19.4M
FCF Margin
LAMR
LAMR
SHC
SHC
Q1 26
28.9%
Q4 25
35.0%
17.3%
Q3 25
31.7%
11.2%
Q2 25
33.0%
8.9%
Q1 25
19.4%
14.0%
Q4 24
40.8%
-3.5%
Q3 24
35.0%
21.4%
Q2 24
41.3%
7.0%
Capex Intensity
LAMR
LAMR
SHC
SHC
Q1 26
6.3%
Q4 25
10.5%
16.7%
Q3 25
8.5%
11.6%
Q2 25
6.6%
10.6%
Q1 25
5.9%
7.8%
Q4 24
7.4%
22.7%
Q3 24
5.3%
12.7%
Q2 24
4.0%
15.2%
Cash Conversion
LAMR
LAMR
SHC
SHC
Q1 26
Q4 25
1.78×
2.96×
Q3 25
1.66×
1.47×
Q2 25
1.49×
7.21×
Q1 25
0.92×
Q4 24
4.52×
Q3 24
1.54×
5.73×
Q2 24
1.87×
7.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LAMR
LAMR

Segment breakdown not available.

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons